Safety and Tolerability Study of Transscleral Iontophoresis by the EyeGate® II Drug Delivery Device System
Clinical trial NCT00698425 · COMPLETED
Trial details
- NCT number
- NCT00698425
- Sponsor
- Eyegate Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2008-12-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.